• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Bystin (BYSL)

ACP18267

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP18267 Target NameBYSL
Target Synonymsby the ribosomal protein s6 gene drosophila homolog like; BYSL; BYST_HUMAN; Bystin; bystin likeFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-437
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ13895
Background Information
  • Uniprot Id

    Q13895

  • Target Species

    Human

  • Target Name

    BYSL

  • Target Full Name

    Bystin

  • Target Function

    Required for processing of 20S pre-rRNA precursor and biogenesis of 40S ribosomal subunits. May be required for trophinin-dependent regulation of cell adhesion during implantation of human embryos.

  • Target Subcellular Location

    Cytoplasm. Nucleus, nucleolus. Note=Associated with 40S ribosomal subunits.

  • Target Protein Families

    Bystin family

  • Target Tissue Specificity

    Found in the placenta from the sixth week of pregnancy. Was localized in the cytoplasm of the syncytiotrophoblast in the chorionic villi and in endometrial decidual cells at the uteroplacental interface. After week 10, the level decreased and then disappe

  • Target Synonyms

    by the ribosomal protein s6 gene drosophila homolog like; BYSL; BYST_HUMAN; Bystin; bystin like

Inquire Recombinant Human Bystin (BYSL) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification